Login / Signup

Cyanoarylporphyrazine dyes: multimodal compounds for personalised photodynamic therapy.

Natalia Yu ShilyaginaLydia N ShestakovaNina N PeskovaS A LermontovaT S LyubovaLarisa G KlapshinaIrina V Balalaeva
Published in: Biophysical reviews (2023)
Photodynamic therapy is known as an effective primary and adjuvant anticancer treatment. Compounds with improved properties or additional modalities are still needed to create an 'ideal' photosensitizer. In this article, we review cyanoarylporphyrazine dyes for photodynamic (anticancer) therapy that we have synthesised to date. The review provides information on the chemistry of cyanoarylporphyrazines, photophysical properties, cellular uptake features and the use of various carriers for selective delivery of cyanoarylporphyrazines to the tumour. The potential of cyanoarylporphyrazines as photodynamic anti-tumour agents also has been evaluated. The most interesting feature of cyanoarylporphyrazines is the dependence of the fluorescence quantum yield and excited state lifetime on the viscosity of the medium, which makes it possible to use them as viscosity sensors in photodynamic therapy. In the future, we expect that the unique combination of photosensitizer and viscosity sensor properties of cyanoarylporphyrazines will provide a tool for dosimetry and tailoring treatment regimens in photodynamic therapy to the individual characteristics of each patient.
Keyphrases
  • photodynamic therapy
  • fluorescence imaging
  • machine learning
  • early stage
  • cancer therapy
  • stem cells
  • deep learning
  • case report
  • combination therapy
  • risk assessment